Teleflex Incorporated (TFX) Inventory Turnover Ratio, from second quarter 2026 to second quarter 2025, current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 
Teleflex Incorporated  (NYSE: TFX)
 

Teleflex Incorporated Inventory Turnover Ratio (COS)

Cost of Sales Formula, Quarterly Results, Trends, Rankings, Statistics

Teleflex Incorporated inventory turnover ratio, the Teleflex Incorporated's ability to sell and replace its inventory in the second quarter 2026, sequentially increased to 1.42 in the second quarter 2026, yet the ratio remained below the average, as TFX's market remain challenging.Average inventory processing period, for the Teleflex Incorporated in Jun 30 2026 quarter, has decreased to 257 days, compare to 332 days, in the Mar 31 2026 quarter.

Within Healthcare sector 273 other companies have achieved higher inventory turnover ratio. While in terms of ranking among all other companies, the company has moved form 1039 in the first quarter 2026, to 1741.

TFX Inventory Turnover Ratio using Sales Formula
What is Inventory Turnover Ratio?
What is Teleflex Incorporated Market Share?

What is Inventory Turnover Ratio?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TFX Inventory Turnover Ratio (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 28 2025)
III. Quarter		 (Jun 29 2025)
II. Quarter
Y / Y Inventory Growth -49.27 % -40.86 % 31.83 % 25.4 % 8.91 %
Y / Y Cost of Sales Growth 35.05 % 51.11 % - 38.02 % -46.94 %
Inventory Turnover Ratio (TTM) 1.42 1.1 - 1.88 1.8
TFX's Total Ranking # 1741 # 1039 # 922 # 944 # 1189
Average inventory processing period 257 332 - 194 203
Seq. Inventory Growth -7.6 % -5.82 % -49.61 % 15.68 % 7.72 %
Seq. Cost of Sales Growth -0.57 % - - 160.9 % 11.25 %




Inventory Turnover Ratio Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 123
Healthcare Sector # 274
Overall Market # 1741

Inventory Turnover Ratio Statistics
High Average Low
2.68 2.33 0.86
(Jul 02 2017)   (Dec 31 2025)



TFX Company Profile >> Back to TFX Efficiency Comparisons >> Compare TFX Inventory Turnover Ratio to its Competitors

Financial Statements
Teleflex Incorporated's Inventories $ 352 Millions Visit TFX's Balance sheet
Teleflex Incorporated's Cost of Revenues TTM $ 689 Millions Visit TFX's Income Statement
What are TFX's Sales? Visit TFX's Sales by Segment

Other Inventory Turnover Ratios
Teleflex Incorporated's Inventory to Sales Ratio
U.S. Durable Goods Inventory to Shipment Ratio By Product
Medical Equipment & Supplies Industry Inventory Turnover Trends and Statistics
Healthcare Sector Inventory Turnover Statistics
Inventory Turnover Trends for overall market
TFX's Inventory Turnover Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Inventory Turnover
Lowest Ranking Inventory Turnover
Inventory Turnover for TFX's Competitors
Inventory Turnover Ratio for TFX's Suppliers
Inventory Turnover Ratio for TFX's Customers

You may also want to know
TFX's Sales Growth Rates TFX's Pe Price to earnings ratio TFX's Receivables Turnover Ratio TFX's Stock Quote
TFX's Net Income Growth Rates TFX's Ps Price to Sales ratio TFX's Sales per Employee TFX's Asset Turnover Ratio
TFX's Net Margin TFX's Pb Price to Book ratio TFX's Financial Strength Ratios TFX's Dividend Payout Ratio



Companies with similar Inventory Turnover Ratio for the quarter ending Jun 30 2026, within Healthcare Sector Inventory Turnover Ratio Cost of revenues at quarter ending Jun 30 2026 Inventories at quarter ending Jun 30 2026
Bristol myers Squibb Company  5.37 $ 14,678.000  Millions$ 2,735  Millions
Tactile Systems Technology Inc   5.12 $ 81.349  Millions$ 16  Millions
Integer Holdings Corporation  5.03 $ 1,369.168  Millions$ 272  Millions
Collegium Pharmaceutical Inc   4.99 $ 293.290  Millions$ 59  Millions
Harrow Inc   4.93 $ 73.636  Millions$ 15  Millions
Ufp Technologies Inc   4.93 $ 452.046  Millions$ 92  Millions
Veracyte Inc   4.84 $ 102.741  Millions$ 21  Millions
West Pharmaceutical Services Inc   4.72 $ 2,103.100  Millions$ 445  Millions
Henry Schein Inc   4.68 $ 9,342.000  Millions$ 1,997  Millions
Guardant Health Inc   4.53 $ 413.947  Millions$ 91  Millions
Integrated Biopharma Inc  4.50 $ 41.768  Millions$ 9  Millions
Idexx Laboratories Inc  4.44 $ 1,714.440  Millions$ 386  Millions
Cryoport inc   4.40 $ 98.679  Millions$ 22  Millions
Envista Holdings Corporation  4.37 $ 1,278.500  Millions$ 293  Millions
Vericel Corporation  4.30 $ 77.922  Millions$ 18  Millions
Myomo Inc   4.23 $ 14.262  Millions$ 3  Millions
Adc Therapeutics Sa  4.17 $ 5.806  Millions$ 1  Millions
Scilex Holding Company  4.08 $ 14.867  Millions$ 4  Millions
Medinotec Inc   4.08 $ 4.736  Millions$ 1  Millions
Alpha Teknova Inc   4.08 $ 28.288  Millions$ 7  Millions
3m Company  4.07 $ 15,258.000  Millions$ 3,754  Millions
Coherus Oncology inc   4.03 $ 15.822  Millions$ 4  Millions
Electromed Inc   4.02 $ 14.133  Millions$ 4  Millions
Novocure Limited  4.02 $ 166.921  Millions$ 41  Millions
Koru Medical Systems Inc   3.97 $ 16.948  Millions$ 4  Millions
Elite Pharmaceuticals Inc   3.95 $ 78.824  Millions$ 20  Millions
Escalon Medical Corp   3.94 $ 7.167  Millions$ 2  Millions
Lftd Partners Inc   3.89 $ 29.233  Millions$ 8  Millions
Pmgc Holdings Inc   3.87 $ 1.364  Millions$ 0  Millions
Sonoma Pharmaceuticals Inc   3.83 $ 13.392  Millions$ 3  Millions

Date modified: 2026-09-08T15:11:45+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.